Muszlak M, Lartigau-Roussin C, Farthouat L, Petinelli M, Hebert J-C, Santiago J
Service de pédiatrie et néonatologie, centre hospitalier de Mayotte, Mamoudzou, Mayotte, France.
Arch Pediatr. 2007 Sep;14(9):1132-6. doi: 10.1016/j.arcped.2007.05.003. Epub 2007 Jun 12.
Hepatitis B virus (HBV) is responsible for a worldwide mortality of 1 million people each year. It constitutes a major public health problem, especially in highly endemic zones, where it concerns the youngest children, primarily by a mother to child transmission, with a strong risk of chronic hepatitis infection and hepatocellular carcinoma. Immunisation of children versus HBV is known to be efficient and safe. In Mayotte, a French overseas territory in Indian Ocean, immunisation versus HBV has been introduced since 1993 in the vaccine schedule, starting at day 1 of life. We report hereby the local experience and practice on HBV infection, state of vaccine coverage, and difficulties met with this major public health issue.
乙型肝炎病毒（HBV）每年在全球导致100万人死亡。它构成了一个重大的公共卫生问题，尤其是在高流行地区，在这些地区，它主要影响幼儿，主要通过母婴传播，慢性肝炎感染和肝细胞癌的风险很高。儿童接种乙肝疫苗被认为是有效且安全的。马约特岛是印度洋上的一个法国海外领地，自1993年起，乙肝疫苗接种已被纳入疫苗接种计划，从出生第一天开始。我们在此报告当地关于乙肝病毒感染的经验和做法、疫苗接种覆盖率以及在这个重大公共卫生问题上遇到的困难。
